Suppr超能文献

高危型人乳头瘤病毒E6蛋白在p53内有两个不同的结合位点,其中只有一个决定降解作用。

High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.

作者信息

Li X, Coffino P

机构信息

Department of Microbiology and Immunology, University of California, San Francisco, California 94143, USA.

出版信息

J Virol. 1996 Jul;70(7):4509-16. doi: 10.1128/JVI.70.7.4509-4516.1996.

Abstract

Human papillomavirus (HPV) E6 protein can inactivate tumor suppressor p53 by inducing its degradation. We now find that high-risk HPV E6 binds to p53 at two distinct sites; one is within the core structure of p53, and another is at the C terminus of p53. Binding to the core of p53 is required for E6-mediated degradation, as shown by deletion analysis and the properties of a point mutant at residue 135. Both low- and high-risk HPV E6 can bind to a C-terminal region of p53, but these interactions do not induce degradation. These results resolve previous seemingly contradictory findings that attributed the distinctive functional properties of high- and low-risk E6 proteins to either a difference in their abilities to associate with p53 or a difference in their N-terminal structures.

摘要

人乳头瘤病毒(HPV)E6蛋白可通过诱导肿瘤抑制因子p53降解来使其失活。我们现在发现,高危型HPV E6在两个不同位点与p53结合;一个位于p53的核心结构内,另一个位于p53的C末端。缺失分析以及135位残基点突变体的特性表明,与p53核心结合是E6介导降解所必需的。低危型和高危型HPV E6均可与p53的C末端区域结合,但这些相互作用不会诱导降解。这些结果解决了先前看似相互矛盾的发现,即高危型和低危型E6蛋白的独特功能特性要么归因于它们与p53结合能力的差异,要么归因于它们N末端结构的差异。

相似文献

5
Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Int J Cancer. 2001 Mar 15;91(6):822-7. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1130>3.0.co;2-0.
7
Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins.
EMBO J. 1992 Jul;11(7):2425-31. doi: 10.1002/j.1460-2075.1992.tb05307.x.
8
Inhibition of p53 DNA binding by human papillomavirus E6 proteins.
J Virol. 1994 Jul;68(7):4262-73. doi: 10.1128/JVI.68.7.4262-4273.1994.
10
Molecular analysis of the interaction between HPV type 16 E6 and human E6-associated protein.
FEBS Lett. 1997 Oct 13;416(1):6-10. doi: 10.1016/s0014-5793(97)01160-5.

引用本文的文献

1
Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations.
Front Immunol. 2025 Jun 2;16:1601572. doi: 10.3389/fimmu.2025.1601572. eCollection 2025.
2
Genome composition-based deep learning predicts oncogenic potential of HPVs.
Front Cell Infect Microbiol. 2024 Jul 22;14:1430424. doi: 10.3389/fcimb.2024.1430424. eCollection 2024.
4
Suppression of E6 Oncogene Induces Apoptosis in CaSki Cervical Cancer Cells.
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3389-3395. doi: 10.31557/APJCP.2023.24.10.3389.
5
Advances in Targeted Therapy for the Treatment of Cervical Cancer.
J Clin Med. 2023 Sep 15;12(18):5992. doi: 10.3390/jcm12185992.
6
Feline papillomavirus-associated Merkel cell carcinoma: a comparative review with human Merkel cell carcinoma.
J Vet Med Sci. 2023 Nov 18;85(11):1195-1209. doi: 10.1292/jvms.23-0322. Epub 2023 Sep 22.
7
High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation.
Front Cell Infect Microbiol. 2022 Jun 27;12:929666. doi: 10.3389/fcimb.2022.929666. eCollection 2022.

本文引用的文献

3
Analysis of a protein-binding domain of p53.
Mol Cell Biol. 1993 Jun;13(6):3811-20. doi: 10.1128/mcb.13.6.3811-3820.1993.
5
p53 domains: identification and characterization of two autonomous DNA-binding regions.
Genes Dev. 1993 Dec;7(12B):2575-86. doi: 10.1101/gad.7.12b.2575.
8
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.
Nature. 1993 Dec 16;366(6456):707-10. doi: 10.1038/366707a0.
9
p21 is a universal inhibitor of cyclin kinases.
Nature. 1993 Dec 16;366(6456):701-4. doi: 10.1038/366701a0.
10
WAF1, a potential mediator of p53 tumor suppression.
Cell. 1993 Nov 19;75(4):817-25. doi: 10.1016/0092-8674(93)90500-p.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验